Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Moodys
Citi
Queensland Health
Chubb
Deloitte
Colorcon
Mallinckrodt
Chinese Patent Office

Generated: August 17, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for BUCLADIN-S

« Back to Dashboard

Bulk Pharmaceutical API Sources for BUCLADIN-S

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ➤ Try a Free Trial 65463 ➤ Try a Free Trial
ABI Chem ➤ Try a Free Trial AC1L23AJ ➤ Try a Free Trial
BioChemPartner ➤ Try a Free Trial BCP0726000050 ➤ Try a Free Trial
BioChemPartner ➤ Try a Free Trial BCP9000459 ➤ Try a Free Trial
Anward ➤ Try a Free Trial ANW-66382 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
UBS
Chinese Patent Office
Colorcon
Johnson and Johnson
Dow
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.